Table 2.
Complications of focal prostate ablation
| Study (references) | Ablation modality | Design | Participants (n) | Urinary tract infection rate | No pad continence (6 month) | Erectile dysfunction (%) | Fistula rate | Urinary retention rate | Hematuria |
| Ahmed et al. 2015 [26▪] | HIFU | Prospective cohort | 56 | 18% | 96% | 25% | 0% | – | 64% |
| Guillaumier et al. 2018 [25▪▪] | HIFU | Prospective cohort | 625 | 9% | 97% | – | 40% | – | – |
| von Hardenberg et al. 2018 [28] | HIFU | Prospective cohort | 24 | 17% | 88% | 20% | – | 13% | 8% |
| Eggener et al. 2016 [35] | FLA | Prospective cohort | 27 | – | – | 0% | – | 8% | 15% |
| Natarajan et al. 2016 [37] | FLA | Prospective cohort | 10 | – | 100% | 0% | – | – | – |
| Lindner et al. 2009 [39] | FLA | Prospective cohort | 12 | – | – | 0% | 0% | 0% | 17% |
| Mendez et al. 2015 [43] | Cryotherapy | Prospective cohort | 317 | – | 100% | 31% | 2% | 1% | – |
| Valerio et al. 2017 [44] | Cryotherapy | prospective cohort | 18 | 17% | – | 0% | – | 17% | – |
| Tay et al. et al. 2017 [45] | Cryotherapy | Propensity matched case controlled | 166 | – | 95% | 30% | 0% | 7% | – |
| Van den Bos et al. 2018 [48▪] | IRE | Prospective cohort | 63 | – | 98% | 23% | – | 2% | – |
| Azzouzi et al. 2018 [50▪▪]/Gill et al. 2018 [49▪▪] | PDT | Prospective randomized controlled | 413 | 21% | 99% | 38% | – | 16% | 28% |
Key.
Unavailable data is represented by a dash (–).
FLA, focal laser ablation; HIFU, high-intensity focal ultrasound, IRE, irreversible electroporation; PDT, photodynamic therapy.